Trial
NCT04450316
Low-dose Naltrexone for Bladder Pain Syndrome
Phase IISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
Stanford University
Collaborators
—
Condition
Bladder Pain Syndrome
Intervention
Naltrexone
Why stopped
Study temporarily suspended awaiting research personnel to resume recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-12-22